|
Name |
Scopularide A
|
Molecular Formula | C36H57N5O7 | |
IUPAC Name* |
(3S,6S,9R,12S,19S)-3-benzyl-6-methyl-9-(2-methylpropyl)-19-octan-2-yl-12-propan-2-yl-1-oxa-4,7,10,13,16-pentazacyclononadecane-2,5,8,11,14,17-hexone
|
|
SMILES |
CCCCCCC(C)[C@@H]1CC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O1)CC2=CC=CC=C2)C)CC(C)C)C(C)C
|
|
InChI |
InChI=1S/C36H57N5O7/c1-8-9-10-12-15-24(6)29-20-30(42)37-21-31(43)41-32(23(4)5)35(46)39-27(18-22(2)3)34(45)38-25(7)33(44)40-28(36(47)48-29)19-26-16-13-11-14-17-26/h11,13-14,16-17,22-25,27-29,32H,8-10,12,15,18-21H2,1-7H3,(H,37,42)(H,38,45)(H,39,46)(H,40,44)(H,41,43)/t24?,25-,27+,28-,29-,32-/m0/s1
|
|
InChIKey |
HQEBGENSMXBRMP-YZURKTGCSA-N
|
|
Synonyms |
SCOPULARIDE A; CHEMBL507120
|
|
CAS | NA | |
PubChem CID | 24899412 | |
ChEMBL ID | CHEMBL507120 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 671.9 | ALogp: | 6.0 |
HBD: | 5 | HBA: | 7 |
Rotatable Bonds: | 11 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 172.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 48 | QED Weighted: | 0.176 |
Caco-2 Permeability: | -5.325 | MDCK Permeability: | 0.00007380 |
Pgp-inhibitor: | 0.999 | Pgp-substrate: | 0.942 |
Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.824 |
30% Bioavailability (F30%): | 0.922 |
Blood-Brain-Barrier Penetration (BBB): | 0.032 | Plasma Protein Binding (PPB): | 92.67% |
Volume Distribution (VD): | 0.436 | Fu: | 2.22% |
CYP1A2-inhibitor: | 0.002 | CYP1A2-substrate: | 0.022 |
CYP2C19-inhibitor: | 0.237 | CYP2C19-substrate: | 0.062 |
CYP2C9-inhibitor: | 0.468 | CYP2C9-substrate: | 0.031 |
CYP2D6-inhibitor: | 0.007 | CYP2D6-substrate: | 0.055 |
CYP3A4-inhibitor: | 0.931 | CYP3A4-substrate: | 0.184 |
Clearance (CL): | 3.856 | Half-life (T1/2): | 0.341 |
hERG Blockers: | 0.025 | Human Hepatotoxicity (H-HT): | 0.796 |
Drug-inuced Liver Injury (DILI): | 0.188 | AMES Toxicity: | 0.008 |
Rat Oral Acute Toxicity: | 0.55 | Maximum Recommended Daily Dose: | 0.271 |
Skin Sensitization: | 0.071 | Carcinogencity: | 0.029 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.005 |
Respiratory Toxicity: | 0.08 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002515 | 0.939 | D0J7XL | 0.368 | ||||
ENC002373 | 0.644 | D09OOV | 0.343 | ||||
ENC005276 | 0.571 | D0X9PF | 0.319 | ||||
ENC005273 | 0.557 | D0L7LC | 0.316 | ||||
ENC005275 | 0.541 | D02XIY | 0.315 | ||||
ENC004731 | 0.531 | D02SBQ | 0.311 | ||||
ENC003950 | 0.502 | D09ZIO | 0.306 | ||||
ENC005272 | 0.490 | D0M2YE | 0.306 | ||||
ENC005274 | 0.480 | D0D8XY | 0.305 | ||||
ENC005271 | 0.478 | D0M3FJ | 0.303 |